| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1,4-alpha-glucan branching enzyme 1 | 0.612 | 0.654 | 1.1E-12 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.060 | None | 1.000 | 6 | 4 | 2004 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
phenotype | 0.060 | None | 1.000 | 6 | 1 | 2004 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
phenotype | 0.070 | None | 1.000 | 7 | 1 | 1999 | 2016 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2006 | 2016 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABCB10 pseudogene 1 | 0.839 | 0.231 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
acetylserotonin O-methyltransferase | 0.691 | 0.346 | 1.3E-20 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2012 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
activating signal cointegrator 1 complex subunit 1 | 0.495 | 0.846 | 2.6E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |